4basebio PLC (FRA:88Q)
Germany · Delayed Price · Currency is EUR 6.85
0.00 (0.00%)
At close: Jan 14, 2026
4basebio Market Cap
4basebio has a market cap or net worth of €105.39 million as of January 14, 2026. Its market cap has decreased by -43.75% in one year.
Market Cap
105.39M
Enterprise Value
93.07M
Revenue
2.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
€6.85
Market Cap Chart
Since February 17, 2021, 4basebio's market cap has increased from 47.83M to 105.39M, an increase of 120.34%. That is a compound annual growth rate of 17.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 105.38M | -3.42% |
| Dec 31, 2025 | 109.11M | -41.76% |
| Dec 31, 2024 | 187.36M | 94.08% |
| Dec 29, 2023 | 96.54M | -2.09% |
| Dec 30, 2022 | 98.60M | 9.32% |
| Dec 31, 2021 | 90.19M | 88.56% |
| Feb 17, 2021 | 47.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 248.76B |
| Siemens Aktiengesellschaft | 203.39B |
| Allianz SE | 144.49B |
| Deutsche Telekom AG | 133.00B |
| Siemens Energy AG | 111.02B |
| Rheinmetall AG | 86.72B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 66.49B |
| Deutsche Bank Aktiengesellschaft | 64.24B |